In one paragraphArticle in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02749474 (Maternal Cancer Diagnosis and Treatment During Pregnancy), which is not on this map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being
Typeobservational_patient_registrySponsorThe Cooper Health SystemRan2003 to 2025Enrolled400ConditionsPregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Faheem FarooqDivision of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
Justin S BrandtDivision of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.ORCID 0000-0002-3194-1087 Evgeniya PolushkinaNational Medical Research Centre for Obstetrics, Gynaecology and Perinatology named after Academician V.I. Kulakov of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.ORCID 0000-0002-1945-0154 Julie VoseDivision of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Fred and Pamela Buffett Cancer Center, Omaha, NE.ORCID 0000-0003-1015-7434 Praveen Ramakrishnan GeethakumariDivision of Hematologic Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.
Hesham YasinHematology/Oncology and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA.ORCID 0000-0002-1130-3125 Umar FarooqHematology/Oncology and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA.ORCID 0000-0001-7891-9891 Nada HamadDepartment of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia.ORCID 0000-0001-7929-1450 Mina Mhallem GziriDepartment of Obstetrics, Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium.ORCID 0000-0003-3528-2389 Karina Dahl SteffensenCenter for Shared Decsion Making, Lillebaelt University Hospital of Southern Denmark, Vejle, Denmark.ORCID 0000-0002-9217-3907 Frédéric AmantCenter for Gynecological Oncology, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-5452-4905 Andrew M EvensDivision of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.ORCID 0000-0002-6900-1824 Funding
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0MNCI NIH HHS P30 CA086862
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
LymphomaNeoplasm Recurrence, LocalFemaleHumansPregnancy
Identifiers
PMID37259563
PMCPMC10515306
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390